Aitia
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $450k | Debt | |
$5.0m | Early VC | ||
$9.9m | Series A | ||
$10.0m | Series B | ||
N/A | $750k | Debt | |
N/A | $8.1m | Early VC | |
$10.0m | Series C | ||
N/A | $4.0m | Early VC | |
$6.0m | Early VC | ||
$23.0m | Series D | ||
Total Funding | €69.1m |
Recent News about Aitia
EditGNS Healthcare is a leading provider of AI-driven precision medicine solutions, focusing on optimizing drug discovery and improving healthcare outcomes. The company operates in the healthcare and pharmaceutical markets, serving clients such as pharmaceutical companies, healthcare providers, and insurance firms. GNS Healthcare leverages advanced machine learning and big data analytics to create predictive models that help in identifying effective treatments and improving patient care. The business model revolves around offering software-as-a-service (SaaS) solutions and consulting services, generating revenue through subscription fees and project-based engagements. By integrating vast amounts of clinical and genomic data, GNS Healthcare enables its clients to make data-driven decisions, ultimately enhancing the efficiency and effectiveness of healthcare delivery.
Keywords: AI, precision medicine, drug discovery, healthcare outcomes, machine learning, big data, predictive models, SaaS, genomic data, data-driven decisions.